SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-002177
Filing Date
2022-08-09
Accepted
2022-08-09 16:12:04
Documents
62
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nwbo-20220630x10q.htm   iXBRL 10-Q 1800554
2 EX-31.1 nwbo-20220630xex31d1.htm EX-31.1 12773
3 EX-32.1 nwbo-20220630xex32d1.htm EX-32.1 8535
  Complete submission text file 0001410578-22-002177.txt   7911770

Data Files

Seq Description Document Type Size
4 EX-101.SCH nwbo-20220630.xsd EX-101.SCH 57544
5 EX-101.CAL nwbo-20220630_cal.xml EX-101.CAL 46720
6 EX-101.DEF nwbo-20220630_def.xml EX-101.DEF 225368
7 EX-101.LAB nwbo-20220630_lab.xml EX-101.LAB 383468
8 EX-101.PRE nwbo-20220630_pre.xml EX-101.PRE 328421
56 EXTRACTED XBRL INSTANCE DOCUMENT nwbo-20220630x10q_htm.xml XML 1719378
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 221148425
SIC: 2834 Pharmaceutical Preparations